title: [GM-CSF: its use in onco-hematologic diseases].
authors.forename: G
authors.initials: G
authors.lastname: Visani
authors.forename: P
authors.initials: P
authors.lastname: Tosi
authors.forename: D
authors.initials: D
authors.lastname: Benfenati
authors.forename: R
authors.initials: R
authors.lastname: Colombini
authors.forename: A R
authors.initials: AR
authors.lastname: Cenacchi
authors.forename: B
authors.initials: B
authors.lastname: Gamberi
authors.forename: R M
authors.initials: RM
authors.lastname: Lemoli
authors.forename: S
authors.initials: S
authors.lastname: Tura
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000380:Agranulocytosis / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003115:Colony-Stimulating Factors / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000009:adverse effects / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D014411:Neoplastic Stem Cells / Q000187:drug effects; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
vernacular_title: Il GM-CSF: impiego nelle malattie oncoematologiche.